{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:31:16Z","timestamp":1790519476268,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-15-CE14-0026-03"],"award-info":[{"award-number":["ANR-15-CE14-0026-03"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR16-CE14-0022-02"],"award-info":[{"award-number":["ANR16-CE14-0022-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Association Francophone des Glycog\u00e9noses"},{"name":"the Ligue r\u00e9gionale contre le cancer"},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"crossref","award":["ECO20160736048"],"award-info":[{"award-number":["ECO20160736048"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004099","name":"Ligue nationale contre le cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.molmet.2018.07.006","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T02:53:23Z","timestamp":1533092003000},"page":"100-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context"],"prefix":"10.1016","volume":"16","author":[{"given":"Laure","family":"Monteillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gjorgjieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Verzieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Imikirene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Duchampt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Guillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Mithieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Rajas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.molmet.2018.07.006_bib1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/kisup.2013.79","article-title":"Risk factors for chronic kidney disease: an update","volume":"3","author":"Kazancio\u011flu","year":"2013","journal-title":"Kidney International Supplements"},{"issue":"5","key":"10.1016\/j.molmet.2018.07.006_bib2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s10620-016-4085-6","article-title":"Hepatocellular carcinoma in obesity, type 2 diabetes, and NAFLD","volume":"61","author":"Reeves","year":"2016","journal-title":"Digestive Diseases and Sciences"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00041433-200306000-00008","article-title":"Lipotoxicity: when tissues overeat","volume":"14","author":"Schaffer","year":"2003","journal-title":"Current Opinion in Lipidology"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib4","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance","volume":"218","author":"Asrih","year":"2013","journal-title":"Journal of Endocrinology"},{"issue":"4","key":"10.1016\/j.molmet.2018.07.006_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","article-title":"Renal lipid metabolism and lipotoxicity","volume":"19","author":"Bobulescu","year":"2010","journal-title":"Current Opinion in Nephrology and Hypertension"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"Journal of Lipid Research"},{"issue":"2","key":"10.1016\/j.molmet.2018.07.006_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.molmet.2018.07.006_bib8","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3748\/wjg.v21.i14.4103","article-title":"Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question","volume":"21","author":"Streba","year":"2015","journal-title":"World Journal of Gastroenterology \u2013 WJG"},{"issue":"5","key":"10.1016\/j.molmet.2018.07.006_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"The Lancet \u2013 Diabetes & Endocrinology"},{"issue":"17","key":"10.1016\/j.molmet.2018.07.006_bib10","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/hmg\/ddw224","article-title":"Progressive development of renal cysts in glycogen storage disease type I","volume":"25","author":"Gjorgjieva","year":"2016","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.08.014","article-title":"Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas","volume":"54","author":"Mutel","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2018.07.006_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1566524013364112","article-title":"The molecular basis of type 1 glycogen storage diseases","volume":"1","author":"Chou","year":"2001","journal-title":"Current Molecular Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2018.07.006_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1172-6-27","article-title":"Glucose-6-phosphatase deficiency","volume":"6","author":"Froissart","year":"2011","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"11","key":"10.1016\/j.molmet.2018.07.006_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genetics in Medicine \u2013 Official Journal of the American College of Medical Genetics"},{"issue":"6","key":"10.1016\/j.molmet.2018.07.006_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cmet.2017.04.032","article-title":"Gut-brain glucose signaling in energy homeostasis","volume":"25","author":"Soty","year":"2017","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2018.07.006_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/2326409816679429","article-title":"Mechanisms by which metabolic reprogramming in GSD1 liver generates a favorable tumorigenic environment","volume":"4","author":"Gjorgjieva","year":"2016","journal-title":"Journal of Inborn Errors of Metabolism and Screening"},{"issue":"4","key":"10.1016\/j.molmet.2018.07.006_bib17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ki.2014.102","article-title":"Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy","volume":"86","author":"Clar","year":"2014","journal-title":"Kidney International"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.molmet.2018.07.006_bib18","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1007\/BF02679990","article-title":"Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"European Journal of Pediatrics"},{"issue":"6","key":"10.1016\/j.molmet.2018.07.006_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1203\/PDR.0b013e31816c9013","article-title":"Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a","volume":"63","author":"Bandsma","year":"2008","journal-title":"Pediatric Research"},{"issue":"5","key":"10.1016\/j.molmet.2018.07.006_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.diabet.2013.03.002","article-title":"Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders","volume":"39","author":"Rajas","year":"2013","journal-title":"Diabetes & Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10545-017-0124-5","article-title":"Flux analysis of inborn errors of metabolism","volume":"41","author":"Reijngoud","year":"2018","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1","key":"10.1016\/j.molmet.2018.07.006_bib22","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/BF02679998","article-title":"Disturbed lipid metabolism in glycogen storage disease type 1","volume":"161","author":"Bandsma","year":"2014","journal-title":"European Journal of Pediatrics"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10545-015-9811-2","article-title":"Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions","volume":"38","author":"Derks","year":"2015","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.molmet.2018.07.006_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jhep.2012.09.030","article-title":"Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I","volume":"58","author":"Calderaro","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005176-199703000-00008","article-title":"Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature","volume":"24","author":"Labrune","year":"1997","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1016\/j.molmet.2018.07.006_bib27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/ijms17040562","article-title":"NAFLD and chronic kidney disease","volume":"17","author":"Marcuccilli","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.molmet.2018.07.006_bib28","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jhep.2017.08.024","article-title":"Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: a cohort study","volume":"67","author":"Sinn","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2018.07.006_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nature Reviews Nephrology"},{"issue":"5","key":"10.1016\/j.molmet.2018.07.006_bib30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00418-006-0263-5","article-title":"Immunocytochemical localization of glucose 6-phosphatase and cytosolic phosphoenolpyruvate carboxykinase in gluconeogenic tissues reveals unsuspected metabolic zonation","volume":"127","author":"Rajas","year":"2007","journal-title":"Histochemistry and Cell Biology"},{"issue":"1","key":"10.1016\/j.molmet.2018.07.006_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2337\/diabetes.51.1.139","article-title":"Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet","volume":"51","author":"Mithieux","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10545-014-9761-0","article-title":"Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease","volume":"38","author":"Rajas","year":"2015","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"8","key":"10.1016\/j.molmet.2018.07.006_bib33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bbalip.2007.05.003","article-title":"PPARalpha and dyslipidemia","volume":"1771","author":"Duval","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"10.1016\/j.molmet.2018.07.006_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","article-title":"Integrated physiology and systems biology of PPAR\u03b1","volume":"3","author":"Kersten","year":"2014","journal-title":"Molecular Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2018.07.006_bib35","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib36","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"49","key":"10.1016\/j.molmet.2018.07.006_bib37","doi-asserted-by":"crossref","first-page":"34036","DOI":"10.1074\/jbc.M109.051052","article-title":"Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice","volume":"284","author":"Oosterveer","year":"2009","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/j.molmet.2018.07.006_bib38","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1194\/jlr.M700108-JLR200","article-title":"Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression","volume":"48","author":"van der Hoogt","year":"2007","journal-title":"Journal of Lipid Research"},{"issue":"6","key":"10.1016\/j.molmet.2018.07.006_bib39","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2018.07.006_bib40","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/hep.29389","article-title":"Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia","volume":"66","author":"Hijmans","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1016\/j.molmet.2018.07.006_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41598-017-00267-9","article-title":"Hyper- and hypo- nutrition studies of the hepatic transcriptome and epigenome suggest that PPAR\u03b1 regulates anaerobic glycolysis","volume":"7","author":"Soltis","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.molmet.2018.07.006_bib42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2165\/00003495-199040020-00007","article-title":"Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia","volume":"40","author":"Balfour","year":"1990","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.molmet.2018.07.006_bib43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.molmet.2014.05.005","article-title":"A\u00a0link between hepatic glucose production and peripheral energy metabolism via hepatokines","volume":"3","author":"Abdul-Wahed","year":"2014","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.molmet.2018.07.006_bib44","doi-asserted-by":"crossref","first-page":"44408","DOI":"10.1038\/srep44408","article-title":"Hepatic mitochondrial dysfunction is a feature of glycogen storage disease type Ia (GSDIa)","volume":"7","author":"Farah","year":"2017","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.molmet.2018.07.006_bib45","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.molmet.2018.07.006_bib46","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.2337\/db11-0571","article-title":"Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice","volume":"60","author":"Mutel","year":"2011","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.molmet.2018.07.006_bib47","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.2337\/db16-0426","article-title":"Interaction of PPAR\u03b1 with the canonic wnt pathway in the regulation of renal fibrosis","volume":"65","author":"Cheng","year":"2016","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2018.07.006_bib48","doi-asserted-by":"crossref","first-page":"e96147","DOI":"10.1371\/journal.pone.0096147","article-title":"Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1\u03b1 in db\/db mice","volume":"9","author":"Hong","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.molmet.2018.07.006_bib49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1258\/ebm.2009.009218","article-title":"Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-\u03baB and transforming growth factor-\u03b21\/Smad3 in diabetic nephropathy","volume":"235","author":"Li","year":"2010","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"issue":"9","key":"10.1016\/j.molmet.2018.07.006_bib50","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/sj.ki.5000209","article-title":"PPARalpha agonist fenofibrate improves diabetic nephropathy in db\/db mice","volume":"69","author":"Park","year":"2006","journal-title":"Kidney International"},{"issue":"2","key":"10.1016\/j.molmet.2018.07.006_bib51","doi-asserted-by":"crossref","first-page":"F323","DOI":"10.1152\/ajprenal.00596.2015","article-title":"Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy","volume":"312","author":"Sohn","year":"2017","journal-title":"American Journal of Physiology \u2013 Renal Physiology"},{"issue":"8","key":"10.1016\/j.molmet.2018.07.006_bib52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/ki.2010.530","article-title":"Fenofibrate, a PPAR\u03b1 agonist, has renoprotective effects in mice by enhancing renal lipolysis","volume":"79","author":"Tanaka","year":"2011","journal-title":"Kidney International"},{"issue":"6","key":"10.1016\/j.molmet.2018.07.006_bib53","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diabetes.47.6.859","article-title":"Protein kinase C activation and the development of diabetic complications","volume":"47","author":"Koya","year":"1998","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2018.07.006_bib54","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4254\/wjh.v5.i9.470","article-title":"Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease","volume":"5","author":"Kostapanos","year":"2013","journal-title":"World Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2018.07.006_bib55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1194\/jlr.M070631","article-title":"Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase","volume":"58","author":"van der Veen","year":"2017","journal-title":"Journal of Lipid Research"},{"issue":"2","key":"10.1016\/j.molmet.2018.07.006_bib56","first-page":"131","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: epidemiology, pathogenesis, and prevention","volume":"1","author":"Baffy","year":"2013","journal-title":"Journal of Clinical and Translational Hepatology"},{"key":"10.1016\/j.molmet.2018.07.006_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/572405","article-title":"Role of PPAR\u03b1 in hepatic carbohydrate metabolism","volume":"2010","author":"Peeters","year":"2010","journal-title":"PPAR Research"},{"issue":"6","key":"10.1016\/j.molmet.2018.07.006_bib58","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2017.08.018","article-title":"A\u00a0fatty liver leads to decreased kidney function?","volume":"67","author":"Targher","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"1\u20133","key":"10.1016\/j.molmet.2018.07.006_bib59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000452727","article-title":"Lipid-lowering therapy in CKD: should we use it and in which patients","volume":"43","author":"Kaysen","year":"2017","journal-title":"Blood Purification"},{"issue":"5","key":"10.1016\/j.molmet.2018.07.006_bib60","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/eci.12068","article-title":"Fenofibrate and the kidney: an overview","volume":"43","author":"Kostapanos","year":"2013","journal-title":"European Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.molmet.2018.07.006_bib61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"10.1016\/j.molmet.2018.07.006_bib62","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jcjd.2017.09.014","article-title":"Effects of pharmacy-based interventions on the control and management of diabetes in adults: a systematic review and meta-analysis","volume":"41","author":"Yaghoubi","year":"2017","journal-title":"Canadian Journal of Diabetes"},{"issue":"4","key":"10.1016\/j.molmet.2018.07.006_bib63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrneph.2012.37","article-title":"Diabetes: should we use fibrates in patients with diabetes and mild CKD?","volume":"8","author":"Lewis","year":"2012","journal-title":"Nature Reviews Nephrology"},{"issue":"2","key":"10.1016\/j.molmet.2018.07.006_bib64","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2337\/dc11-1109","article-title":"Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study","volume":"35","author":"Ting","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2018.07.006_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"issue":"6","key":"10.1016\/j.molmet.2018.07.006_bib66","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"Staels","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221287781830646X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221287781830646X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T20:12:34Z","timestamp":1542053554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221287781830646X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":66,"alternative-id":["S221287781830646X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2018.07.006","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2018.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}